
Drug Maker Eli Lilly (LLY) Caps the Price of Insulin to $35 a Month
Eli Lilly (LLY) capped the price of insulin it provides to Americans at $35 a month. But LLY’s weight loss drug should be the big news.
Eli Lilly (LLY) capped the price of insulin it provides to Americans at $35 a month. But LLY’s weight loss drug should be the big news.
Eli Lilly (LLY) continues to rise as it has developed what could become the next big weight loss drug, pending approval from the FDA.
Eli Lilly (LLY) has two potential blockbuster drugs — for weight loss and Alzheimer’s — that could bring big profits down the road.
Eli Lilly (LLY) is expected to report qtrly profits (EPS) and revenues:
Profits Estimates: $1.80 vs. $2.77 = -35%
Rev Est: $6,827 vs. $7,810 = -13%